Cholesterol Profiles Study
To ascertain the effect of Laminine’s special protein, FGF, a study was done independently with Laminine and in combination with Laminine OMEGA+++ on the following:
- Low-Density Lipoproteins (LDL)
- High-Density Lipoproteins (HDL)
- Blood Pressure.
There were 15 individuals in the two phases of the study, broken into three groups of five. This was a double-blind placebo-controlled study that took place over a total period of 12 weeks.
Dosage experiment of 4 capsules per day
Participants took a total of four supplements a day—two in the morning and two in the evening. During the first phase of the study, results showed that the average cholesterol down-regulation in Group B was about 9.8 percent, compared to 11.5 percent in Group C.
Meanwhile, cholesterol levels in Group A actually rose by 1.0 percent over the first eight weeks but normalized by 11 percent between weeks nine and 12. Results for LDL and triglycerides generally followed a similar pattern.
Bottom line of Laminine cholesterol study
During the first phase, cholesterol down-regulation in Group B (Laminine + placebo) was about 9.8 percent, compared to 11.5 percent in Group C (Laminine + Omega).
Participants in Group C (Laminine + Omega) experienced the best and most consistent overall results. HDL levels were within normal limits both at the beginning and end of the study for all participants.
These data suggest that Laminine OMEGA+++ helps to down-regulate cholesterol, LDL, triglyceride, and blood pressure levels (Group B). Still, when taken with Laminine, the benefits are more significant as a whole (Group C after Phase I and Group A after Phase II).
For individuals that have high triglyceride concerns, doubling the intake of Laminine and Laminine OMEGA+++ can yield a normalization in a short period of time.